This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Jenkem Technology Co., Ltd. (Tianjin). Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Juan Shi - Innovator in Antitumor Pharmaceutical Composition
Introduction: Juan Shi is an inventor based in Tianjin, China, known for his work in the field of pharmaceutical compositions aimed at treating tumors. He is currently employed at Jenkem Technology Co., Ltd. Despite having no granted patents to his name, his research and patent applications demonstrate significant potential in the medical field.
Latest Patent Applications: One of Juan Shi's notable patent applications is titled "ANTITUMOR PHARMACEUTICAL COMPOSITION AND USE THEREOF." This application describes an antitumor pharmaceutical composition that includes active ingredients such as a polyethylene glycol-modified camptothecin derivative, specifically polyethylene glycol-modified irinotecan, and temozolomide. Animal experiments have shown that the combination of these compounds exhibits a strong treatment effect on tumors, such as neuroblastoma, achieving a tumor inhibition rate of 98%. This result is significantly superior to that of monotherapy groups, indicating promising application prospects for the treatment of tumors.
Conclusion: Juan Shi's innovative work in antitumor pharmaceutical compositions highlights his contributions to medical research, despite the absence of granted patents. His ongoing efforts may lead to significant advancements in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile